lidocaine has been researched along with Bone Loss, Perimenopausal in 1 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Radicioni, M | 1 |
| Cremonesi, G | 1 |
| Baraldi, E | 1 |
| Leuratti, C | 1 |
| Mariotti, F | 1 |
1 trial available for lidocaine and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
Pharmacokinetic and tolerability of i.m. disodium clodronate 200 mg/lidocaine 1%, given twice monthly, in comparison with i.m. disodium clodronate 100 mg/lidocaine 1%, given weekly, in healthy postmenopausal female patients.
Topics: Bone Density Conservation Agents; Clodronic Acid; Cross-Over Studies; Dose-Response Relationship, Dr | 2013 |